Page contentsPage contents Key facts Decision Key facts Active substance levonorgestrel Therapeutic area Surgical and medical procedures Decision number EMA/PE/0000240469 PIP number EMA/PE/0000240469 Pharmaceutical form(s) Vaginal delivery system Condition(s) / indication(s) Prevention of pregnancy Route(s) of administration Vaginal use Contact for public enquiries Chemo Research S.L.E-mail: naomi.nunez@exeltis.com Tel.: +34 653535412 Decision type PM: decision on the application for modification of an agreed PIP Decision date 16/05/2025 Compliance check done No Decision EMA/PE/0000240469 : EMA decision of 16 May 2025 on the acceptance of a modification of an agreed paediatric investigation plan for levonorgestrelAdopted Reference Number: EMADOC-1700519818-2113975 English (EN) (253.89 KB - PDF)First published: 07/07/2026 View Share this page